| The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets SL Wood, M Pernemalm, PA Crosbie, AD Whetton Cancer treatment reviews 40 (4), 558-566, 2014 | 435 | 2014 |
| Molecular histology of lung cancer: from targets to treatments SL Wood, M Pernemalm, PA Crosbie, AD Whetton Cancer treatment reviews 41 (4), 361-375, 2015 | 200 | 2015 |
| The viral protein corona directs viral pathogenesis and amyloid aggregation K Ezzat, M Pernemalm, S Pålsson, TC Roberts, P Järver, A Dondalska, ... Nature communications 10 (1), 2331, 2019 | 182 | 2019 |
| Molecular evaluation of five different isolation methods for extracellular vesicles reveals different clinical applicability and subcellular origin RE Veerman, L Teeuwen, P Czarnewski, G Güclüler Akpinar, ... Journal of Extracellular Vesicles 10 (9), e12128, 2021 | 168 | 2021 |
| Network enrichment analysis: extension of gene-set enrichment analysis to gene networks A Alexeyenko, W Lee, M Pernemalm, J Guegan, P Dessen, V Lazar, ... BMC bioinformatics 13, 1-11, 2012 | 147 | 2012 |
| Affinity prefractionation for MS‐based plasma proteomics M Pernemalm, R Lewensohn, J Lehtiö Proteomics 9 (6), 1420-1427, 2009 | 119 | 2009 |
| Advances and utility of the human plasma proteome EW Deutsch, GS Omenn, Z Sun, M Maes, M Pernemalm, KK Palaniappan, ... Journal of proteome research 20 (12), 5241-5263, 2021 | 113 | 2021 |
| Ultrasensitive immunoprofiling of plasma extracellular vesicles identifies syndecan-1 as a potential tool for minimally invasive diagnosis of glioma V Indira Chandran, C Welinder, AS Månsson, S Offer, E Freyhult, ... Clinical Cancer Research 25 (10), 3115-3127, 2019 | 86 | 2019 |
| Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer L De Petris, LM Orre, L Kanter, M Pernemalm, H Koyi, R Lewensohn, ... Lung Cancer 63 (3), 410-417, 2009 | 85 | 2009 |
| Mass spectrometry-based plasma proteomics: state of the art and future outlook M Pernemalm, J Lehtiö Expert review of proteomics 11 (4), 431-448, 2014 | 78 | 2014 |
| Up-regulation, modification, and translocation of S100A6 induced by exposure to ionizing radiation revealed by proteomics profiling LM Orre, M Pernemalm, J Lengqvist, R Lewensohn, J Lehtio Molecular & Cellular Proteomics 6 (12), 2122-2131, 2007 | 76 | 2007 |
| Proteomics analysis of melanoma metastases: association between S100A13 expression and chemotherapy resistance A Azimi, M Pernemalm, M Frostvik Stolt, J Hansson, J Lehtiö, ... British journal of cancer 110 (10), 2489-2495, 2014 | 73 | 2014 |
| Proteomics analysis reveals distinct corona composition on magnetic nanoparticles with different surface coatings: implications for interactions with primary human macrophages C Vogt, M Pernemalm, P Kohonen, S Laurent, K Hultenby, M Vahter, ... PLoS One 10 (10), e0129008, 2015 | 72 | 2015 |
| Quantitative proteomics profiling of primary lung adenocarcinoma tumors reveals functional perturbations in tumor metabolism M Pernemalm, L De Petris, RM Branca, J Forshed, L Kanter, JC Soria, ... Journal of proteome research 12 (9), 3934-3943, 2013 | 66 | 2013 |
| Use of narrow‐range peptide IEF to improve detection of lung adenocarcinoma markers in plasma and pleural effusion M Pernemalm, L De Petris, H Eriksson, E Branden, H Koyi, L Kanter, ... Proteomics 9 (13), 3414-3424, 2009 | 66 | 2009 |
| Evaluation of three principally different intact protein prefractionation methods for plasma biomarker discovery M Pernemalm, LM Orre, J Lengqvist, P Wikstrom, R Lewensohn, J Lehtio Journal of proteome research 7 (7), 2712-2722, 2008 | 65 | 2008 |
| In-depth human plasma proteome analysis captures tissue proteins and transfer of protein variants across the placenta M Pernemalm, AS Sandberg, Y Zhu, J Boekel, D Tamburro, JM Schwenk, ... Elife 8, e41608, 2019 | 63 | 2019 |
| Protein Z: A putative novel biomarker for early detection of ovarian cancer MR Russell, MJ Walker, AJK Williamson, A Gentry‐Maharaj, A Ryan, ... International journal of cancer 138 (12), 2984-2992, 2016 | 62 | 2016 |
| Enhanced information output from shotgun proteomics data by protein quantification and peptide quality control (PQPQ) J Forshed, HJ Johansson, M Pernemalm, RMM Branca, AS Sandberg, ... Molecular & Cellular Proteomics 10 (10), 2011 | 42 | 2011 |
| Silencing FLI or targeting CD13/ANPEP lead to dephosphorylation of EPHA2, a mediator of BRAF inhibitor resistance, and induce growth arrest or apoptosis in melanoma cells A Azimi, R Tuominen, F Costa Svedman, S Caramuta, M Pernemalm, ... Cell Death & Disease 8 (8), e3029-e3029, 2017 | 36 | 2017 |
